LifeVantage Co. (NASDAQ:LFVN) Sees Large Growth in Short Interest

LifeVantage Co. (NASDAQ:LFVN) was the target of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 1,410,000 shares, a growth of 137.5% from the January 31st total of 593,800 shares. Based on an average daily volume of 214,300 shares, the short-interest ratio is presently 6.6 days. Approximately 14.0% of the shares of the company are short sold.

LifeVantage Stock Up 3.6 %

LFVN stock traded up $0.59 during trading on Friday, hitting $17.17. The company had a trading volume of 162,670 shares, compared to its average volume of 298,607. The stock has a market cap of $215.50 million, a price-to-earnings ratio of 30.66 and a beta of 0.84. The firm has a 50-day moving average price of $20.10 and a 200-day moving average price of $14.92. LifeVantage has a 12 month low of $5.22 and a 12 month high of $27.38.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be issued a $0.04 dividend. The ex-dividend date is Monday, March 3rd. This represents a $0.16 annualized dividend and a yield of 0.93%. LifeVantage’s dividend payout ratio is currently 28.57%.

Insider Buying and Selling

In other news, Director Raymond B. Greer sold 8,000 shares of LifeVantage stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $20.15, for a total transaction of $161,200.00. Following the sale, the director now owns 99,288 shares of the company’s stock, valued at approximately $2,000,653.20. This trade represents a 7.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 20.65% of the stock is owned by insiders.

Hedge Funds Weigh In On LifeVantage

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Copeland Capital Management LLC acquired a new position in shares of LifeVantage in the 4th quarter valued at $65,000. Hillsdale Investment Management Inc. lifted its stake in LifeVantage by 7.3% in the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company’s stock valued at $258,000 after buying an additional 1,000 shares during the period. Schonfeld Strategic Advisors LLC acquired a new position in LifeVantage in the fourth quarter valued at about $282,000. OMERS ADMINISTRATION Corp bought a new position in LifeVantage during the fourth quarter worth about $284,000. Finally, Barclays PLC grew its position in shares of LifeVantage by 38.2% during the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock worth $507,000 after buying an additional 11,608 shares during the period. 35.32% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on LFVN shares. Lake Street Capital began coverage on LifeVantage in a research note on Thursday, December 19th. They set a “buy” rating and a $26.00 price objective for the company. Craig Hallum assumed coverage on shares of LifeVantage in a research report on Tuesday, January 14th. They set a “buy” rating and a $35.00 target price for the company.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.